13-Fluorolysergol
Chemical compound
13-Fluorolysergol is a chemical compound that belongs to the class of ergoline derivatives. It is a fluorinated analog of lysergol, which is a naturally occurring ergoline alkaloid. The modification involves the substitution of a fluorine atom at the 13th position of the lysergol molecule.
Chemical Structure and Properties
13-Fluorolysergol is characterized by the presence of a fluorine atom at the 13th position of the ergoline skeleton. This modification can significantly alter the pharmacological properties of the compound compared to its non-fluorinated counterpart, lysergol. The presence of the fluorine atom can affect the compound's lipophilicity, metabolic stability, and receptor binding affinity.
Synthesis
The synthesis of 13-Fluorolysergol involves the introduction of a fluorine atom into the lysergol structure. This can be achieved through various synthetic routes, often involving the use of fluorinating agents. The synthesis process requires careful control of reaction conditions to ensure the selective fluorination at the desired position without affecting other functional groups in the molecule.
Pharmacology
As an ergoline derivative, 13-Fluorolysergol is expected to interact with various serotonin receptors, similar to other compounds in this class. The fluorine substitution may enhance or modify its activity at these receptors, potentially leading to differences in its pharmacological profile. However, detailed studies on its receptor binding and activity are necessary to fully understand its pharmacological effects.
Potential Applications
The unique properties of 13-Fluorolysergol, due to its fluorine substitution, may make it a candidate for research in various fields, including neuropharmacology and medicinal chemistry. Its potential applications could include the development of new therapeutic agents targeting serotonin receptors or as a tool in receptor mapping studies.
Safety and Toxicology
As with many ergoline derivatives, the safety and toxicological profile of 13-Fluorolysergol would need to be thoroughly evaluated. The introduction of a fluorine atom can alter the compound's toxicity and metabolism, necessitating comprehensive studies to assess its safety for any potential therapeutic use.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD